Viewing nowGlipirin Tablets (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
RP Bio Co., Ltd.

MFDS item code 200403680 · Notified 2004.11.11 · Insurance code 661600030
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to assist meal therapy and exercise therapy in order to improve blood sugar control in patients with Type 2 diabetes. It can be administered alone, and in cases where blood sugar control is insufficient with oral hypoglycemic agents, it may be used in combination with insulin. Additionally, when sulfonylureas or metformin monotherapy is insufficiently effective, it can be used in combination with metformin to aid in blood sugar control. This medication is used to effectively improve blood sugar management in patients.
Adjust individually for each patient. Swallow whole without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional effect with doses above 4 mg, but some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider using insulin or another oral antidiabetic medicine in combination. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering medicine to this medicine There is no exact dose equivalence between this medicine and other oral blood glucose-lowering medicines. When switching from another oral blood glucose-lowering medicine to this medicine, it is advisable to follow the method described under Initial dose. That is, treatment may be initiated at 1 mg once daily, and the dose may be adjusted at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered medicine should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully managed at the outset of treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate treatment and follow-up by a physician and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses need to be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate caution should be exercised.
This medication should not be used in patients with insulin-dependent diabetes or in patients experiencing diabetic ketoacidosis or coma. Patients allergic to this medication or sulfonylureas should also avoid its use. Patients with severe liver or kidney impairment should not use this medication and it is recommended to switch to insulin treatment. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication. Patients with severe infections, pre- or post-surgery, or severe trauma may require insulin treatment, so caution should be taken when using this medication. In cases of gastrointestinal disturbances such as diarrhea or vomiting, there is a risk of hypoglycemia due to poor nutrient absorption, so caution is needed. In the first week of treatment, the risk of hypoglycemia is high, and blood sugar levels should be closely monitored, especially for elderly patients, those with malnutrition, inconsistent meals, and alcohol consumers. Patients with reduced renal or liver function or other endocrine disorders have an increased risk of hypoglycemia and should be treated with caution. This medication can cause hypoglycemia, so it is important to be aware of the symptoms of hypoglycemia and to carry sugar at all times. Symptoms of hypoglycemia may include headache, severe hunger, nausea, fatigue, confusion, drowsiness, decreased consciousness, etc., so immediate treatment should be sought in case of abnormal symptoms. Occasionally gastrointestinal symptoms such as blurred vision, nausea, abdominal pain, and diarrhea may appear, so if these symptoms persist, consult a physician. This medication may cause liver dysfunction, blood disorders, or allergic reactions, so any abnormal symptoms should be reported to healthcare personnel immediately. In particular, if allergic symptoms such as hives, rash, or difficulty breathing occur, the medication should be discontinued immediately and medical assistance should be sought. When taking this medication, it is important to adhere to dietary and exercise recommendations and to regularly check blood sugar control status. Using this medication in conjunction with other drugs may affect blood sugar control, so all medications currently being taken should be communicated to healthcare personnel. It is safest to avoid this medication and switch to insulin treatment if pregnant or breastfeeding. In case of overdose, severe hypoglycemia may occur, requiring immediate emergency treatment, which may include inducing vomiting, administration of activated charcoal, or glucose injection. Keep the medication out of reach of children and store it in its original container. Elderly patients may have reduced kidney function, thus it is important to adjust the dosage and administer it carefully. The safety and efficacy of this medication in pediatric patients under 18 years have not been established, therefore its use should be avoided.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from exposure to air and light, and it is best stored at room temperature between 1 to 30 degrees Celsius. This helps to maintain the effectiveness of the medication and ensures safe usage.
Green rectangular tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
RP Bio Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.